Harman Patil (Editor)

Quintiles

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Type
  
Public

Headquarters
  
Durham

CEO
  
Ari Bousbib (Oct 2016–)

Founder
  
Dennis B. Gillings

Quintiles mediadpublicbroadcastingnetpwuncfiles201305

Traded as
  
NYSE: Q Russell 2500 Component

Industry
  
Contract Research Organization Pharmaceutical Service Consulting

Key people
  
Dennis Gillings, Founder Ari Bousbib, Chairman and CEO Tom Pike, Vice-Chairman

Products
  
Support services for pharmaceutical, biotech and medical companies and individuals

Revenue
  
US$ Approximately $4.2 billion in Service Revenue (2014)

Founded
  
February 1982, North Carolina, United States

Parent organization
  
Quintiles IMS Holdings Inc

Subsidiaries
  
MedLab (Pty) Limited, Quintiles B.V., Innovex, Inc.

Quintiles ims health completes global merger


Quintiles IMS Holdings, Inc., branded as QuintilesIMS is an American multinational company serving the combined industries of health information technologies and clinical research. It is a Fortune 500 company and the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 50,000 employees conducting business in approximately 100 countries.

Contents

QuintilesIMS is the world’s largest contract research organization as ranked by reported service revenues, and is focused primarily on Phase II-IV clinical trials and associated laboratory and analytical services.

Quintiles transnational holdings ceo behind the deal mad money cnbc


History

  • In 1982, Dennis Gillings founded and incorporated Quintiles Transnational in North Carolina.
  • Quintiles Transnational established Quintiles Pacific Inc. and Quintiles Ireland Ltd. in 1990, and in 1991 Quintiles GmbH was established in Germany and Quintiles Laboratories Ltd. was established in Atlanta, Georgia.
  • In September 1996, Quintiles purchased Innovex Ltd. of Britain for $747.5 million in stock.
  • Quintiles went public in 1997 and completed a successful secondary stock offering.
  • Over 2016 concluding on October 3, Quintiles underwent a $17.6 billion merger with IMS Health becoming QuintilesIMS.

    • References

    Quintiles Wikipedia
    (Text) CC BY-SA